-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trabectedin in Dedifferentiated Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trabectedin in Dedifferentiated Liposarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trabectedin in Dedifferentiated Liposarcoma Drug Details: Trabectedin (Yondelis) is an anti tumor...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trabectedin in Myxoid Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trabectedin in Myxoid Liposarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trabectedin in Myxoid Liposarcoma Drug Details: Trabectedin (Yondelis) is an anti tumor...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trabectedin in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trabectedin in Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trabectedin in Ovarian Cancer Drug Details: Trabectedin (Yondelis) is an anti tumor...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trabectedin in Soft Tissue Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trabectedin in Soft Tissue Sarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trabectedin in Soft Tissue Sarcoma Drug Details: Trabectedin (Yondelis) is an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trabectedin in Ewing Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trabectedin in Ewing Sarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trabectedin in Ewing Sarcoma Drug Details: Trabectedin (Yondelis) is an anti tumor...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trabectedin in Round Cell Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trabectedin in Round Cell Liposarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trabectedin in Round Cell Liposarcoma Drug Details: Trabectedin (Yondelis) is an...
-
Analyst Opinions
Cruise Industry Overview – Key Trends and Analysis by Types, Destinations, Case Study, Challenges and Opportunities, 2024 Update
Reasons to buy the ‘Key Trends in Cruises’ report: Analyze the key market trends shaping the cruise industry, influenced by COVID-19. Access case studies of companies, sector deals, advertisement activity, challenges, and opportunities in the market. Assess major cruise companies to understand the competitive landscape better. Analyze alternative cruise types to provide valuable insight. Why is our ‘Cruise Industry’ report the best in the market? Gain an insight into the cruise industry’s leading players to understand the market better. Understand...
-
Sector Analysis
Oil and Gas Discoveries Review by Country, Operator, Well Terrain and Resource Type, 2023
Oil and Gas Discoveries Review Report Overview In 2023, about 131 oil and gas discoveries were made globally. The Oil and Gas Discoveries review report provides a count of the discoveries by region, including a country-wise update of 2023. The report also discusses the resource types found in the regions along with the key operators making the oil and gas discoveries. Key Resource Types ·       Conventional Oil ·       Conventional Gas ·       CBM ·       Unconventional Gas ·       Heavy Oil ·       Unconventional...
-
Sector Analysis
Refinery Alkylation Units Capacity and Capital Expenditure Outlook and Forecast with Details of All Operating and Planned Alkylation Units to 2028
Refinery Alkylation Units Market Overview The total refinery alkylation units capacity was 2,629 thousand barrels per day (mbd) in 2023 and it is poised to register an Average Annual Growth Rate (AAGR) of more than 2% from 2023 to 2028. The US, China, Japan, India, and South Korea are the major countries that accounted for 68% of the total global alkylation unit capacity in 2023. Refinery Alkylation Units Capacity and CapEx Outlook, 2022-2027 (mbd) Buy the Full Report for More...